Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
What we found: Currently the evidence does not show that GLP-1 medications increase the risk of depression or suicidality
Communicating with Your Healthcare Provider After illness, update your provider about: How many doses you missed The severity of your illness Any complications or concerns Your plan for resuming treatment They may recommend: Temporary dose adjustment Additional monitoring Lab work to check for any complications Modified return-to-treatment schedule Blood Sugar Considerations (For Those with Diabetes) If you use GLP-1 medications for type 2 diabetes management, illness creates additional complexity because infections affect blood sugar levels
Weight loss data is limited compared to GLP-1 agonists
The newly-required updates expand the existing warning to include kidney disease, and provide additional detail to help consumers identify the signs and symptoms of potential kidney injury, a rare side effect for those who took Orlistat over-the-counter or prescription medicines. These updates reflect Haleons ongoing commitment to transparency, patient safety and alignment with regulatory guidance, they said
SmartTRAK is the Medtech industrys only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets
